Issue link: https://viewer.e-digitaledition.com/i/745482
SCIENCE SNPs PRENATAL TESTING OF DYRK1A INHIBITION IN MICE Hyperactivity of the DYRK1A gene encoded on chromosome 21 is believed to drive some of the ill effects of trisomy 21. In order to define the contribution of DYRK1A to craniofacial abnormalities during embryonic development, researchers at the University of Indiana employed two alternative methods to inhibit DYRK1A function in pregnant mice with trisomic fetuses. On one hand, they employed epigallocatechin-3-gallate (EGCG), the compound in green tea known to inhibit DYRK1A activity. Alternatively, they employed genetic engineering methods to reduce the number of DYRK1A gene copies from three to two in the trisomic fetuses. In both cases they observed a partial normalization of the cranial vault, the space in the skull occupied by the brain. These results suggest that prenatal DYRK1A inhibition may have therapeutic benefits, a notion that would have to be thoroughly explored in the future with appropriate clinical research in humans. Human Molecular Genetics, SEPTEMBER 2016 GENE IMPORTANT FOR SOCIAL BEHAVIOR ON CHROMOSOME 21 While studying changes in gene activity in the brains of rodents, fish, and flies, researchers have found that a specific molecular pathway, known as interferon- gamma, links immunity in the central nervous system with adaptive behavior in social settings. It was well established that interferon-gamma boosts the immune system, but these researchers have shown it is also important for connectivity among neurons and social behavior. This unexpected link suggests immunity is boosted when animals aggregate and interact in groups. Of note, a key molecular component of this pathway, one of the interferon-gamma receptors, is encoded on chromosome 21. These results open the possibility that triplication of the interferon-gamma receptor in people with trisomy 21 could not only hyperactivate the immune system, something with potentially harmful consequences, but also improve neuronal processes required for social behavior. Nature, JULY 2016 FIRST CLINICAL TRIAL FOR COMPOUND IN GREEN TEA A 2016 study conducted in Catalonia, Spain, has found that EGCG may play a role in mitigating the effects of DYRK1A, which may be responsible for many of the neurological and physical effects of Down syndrome, in adults. After one year, young adults with Down syndrome who took purified, concentrated EGCG and participated in nonpharmacological cognitive training experienced greater cognitive improvements than a control group of same-aged young adults with Down syndrome who participated in cognitive training alone. The Lancet Neurology, JULY 2016 A LINK BETWEEN DENTAL HEALTH AND ALZHEIMER'S DISEASE According to a 2016 literature review, chronic periodontal disease is a likely environmental risk factor for Alzheimer's disease in people with Down syndrome, who are more likely to develop periodontal disease and often experience more severe forms of the condition than their typical peers. Research into the exact mechanism responsible for the link is ongoing, but findings underscore the importance of preventing chronic periodontal disease in children and adults with Down syndrome. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, FEBRUARY 2016 GLOBALDOWNSYNDROME.ORG 11

